CRF Health Selected to Support Large Recorded COPD Trial


CRF Health's TrialMax platform has been selected to support a large Phase III study in COPD. The platform will be used to improve efficiency and increase patient-reported outcomes compliance for its 19,000 clinical trial patients.   Read the full release here


Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Applied Clinical Trials and LabConnect
Cat Hall endpoint Clinical
OM1 Sonja Wustrack
Related Content
© 2023 MJH Life Sciences

All rights reserved.